To view this email as a web page, click here.
 
MIGRAINE DRUG
 
Investigational drug appears beneficial in preventing migraines
An investigational treatment for the prevention of episodic and chronic migraine has met its primary endpoint in three phase 3 studies.
Read more
 
Drugmaker recalls samples of antiplatelet drug
This drug maker has voluntarily recalled 1 lot of physician-sample bottles of ticagrelor (Brilinta) 90-mg tablets as a precaution.
Read more
 
How pharma reps impact physician prescribing
Limiting how pharmaceutical sales representatives can market their products to physicians changes their drug prescribing behaviors, according to a new study.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.